3091:HK:HK-NikkoAM E-Games Active ETF USD Class (HKD)

ETF | Others |

Last Closing

USD 103.2

Change

-0.10 (-0.10)%

Market Cap

N/A

Volume

210.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.48 (+2.25%)

USD 161.07B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+2.06 (+2.77%)

USD 20.18B
2801:HK iShares Core MSCI China ETF

+0.72 (+3.31%)

USD 17.71B
2823:HK iShares FTSE A50 China

+0.69 (+4.79%)

USD 14.19B
83188:HK ChinaAMC CSI 300 Index ETF

+2.10 (+5.28%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.09 (+7.14%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.61 (+6.45%)

USD 9.22B
82822:HK CSOP FTSE China A50

+0.55 (+4.52%)

USD 7.65B
9010:HK iShares Core MSCI AC Asia ex J..

+0.05 (+0.59%)

USD 3.03B

ETFs Containing 3091:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.89% 78% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.89% 77% C+ 75% C
Trailing 12 Months  
Capital Gain 34.52% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.52% 83% B 82% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -2.06% N/A N/A 56% F
Dividend Return -2.06% N/A N/A 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.06% N/A N/A 79% B-
Risk Adjusted Return -12.10% N/A N/A 50% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike